Investing Ideas
/
Global Biotech Breakthroughs

Header cover image

Global Biotech Breakthroughs

UPDATED Apr 23, 2024

Biotech stocks worldwide which are expected to become profitable in the next 3 years.

230 companies

	Company	Last Price	7D Return	1Y Return	Market Cap	Analysts Target	Valuation	Growth	Div Yield
	BGNE BeiGene	US$138.99	5.4%	-43.5%	US$14.5b	US$268.64	PS5.9x	E56.2%	n/a
	AMRN Amarin	US$0.88	-3.7%	-29.9%	US$362.7m	US$1.08	PS1.2x	E51.1%	n/a
	ABCM N Abcam	US$292.38	0%	-2.5%	US$3.7b	US$360.48	PS8.1x	E37.2%	0%
	MYD Myriad Genetics	US$26.72	0%	-2.2%	US$1.3b	US$33.52	PS2x	E53.5%	n/a
	VITRS Vitrolife	kr182.25	-4.3%	-11.6%	kr22.2b	kr267.20	PS6.3x	E112.2%	0.6%
	IMMU Mendus	kr0.50	0.6%	-72.8%	kr500.1m	kr1.80	PS17.6x	E61.5%	n/a
	DBVA DBV Technologies	€0.42	-7.5%	-66.0%	€116.2m	€1.67	PS7.9x	E53.3%	n/a
	PHARM Pharming Group	€0.91	-5.6%	-9.5%	€611.5m	€2.00	PS2.7x	E52.9%	n/a
	1YG Mendus	kr0.017	-38.8%	-87.8%	kr500.1m	n/a	PS17.6x	E61.5%	n/a
	TRX Tissue Regenix Group	UK£0.61	0%	0.8%	UK£43.3m	UK£1.20	PS1.8x	E133.0%	n/a
	AUPH Aurinia Pharmaceuticals	US$5.09	3.7%	-54.4%	US$736.1m	US$10.57	PS4.2x	E53.7%	n/a
	0IDA Dynavax Technologies	US$12.01	5.4%	9.7%	US$1.5b	US$25.19	PS6.6x	E41.6%	n/a
	6160 BeiGene	US$82.00	1.2%	-45.4%	US$14.5b	US$158.49	PS5.9x	E56.2%	n/a
	6160 BeiGene	US$82.00	1.2%	-45.4%	US$14.5b	US$158.49	PS5.9x	E56.2%	n/a

Page 10 of 10